Martin Shkreli

114 reviews, 24% of them positive.24% positive · 114 reviews· Influence factor 147, above 29% of accounts

The record

From 112 activities · May 2026

Convicted securities fraudster and former hedge fund manager infamous for raising Daraprim's price from $13.50 to $750 per pill, exploiting immunocompromised patients. Served ~5 years in prison and was released in 2022. Now active in fintech and crypto, building Gödel Terminal and frequently posting on biotech, markets, and trading. Widely recognized as exceptionally intelligent on finance, probability, and drug development, but reputation remains heavily damaged by the Daraprim scandal, fraud conviction, and repeated involvement in crypto pump-and-dump schemes. Presence characterized by provocative, unfiltered commentary that generates both sharp market insights and persistent distrust—described variously as brilliant yet toxic, knowledgeable yet manipulative, and impossible to separate from a legacy of greed and ethical violations.

What people say

Received · 114 Given · 0

“Pharma Bro in Crypto: Endless Noise and the Illusion of Reputation”We’ve seen plenty of actors in this market, but characters like Shkreli shift narratives every cycle solely to drain retail liquidity and capture attention; from the DJT token fiasco to his latest AI and hardware pivots, it’s nothing but speculative noise detached from on-chain ethics. Veteran traders learned long ago to quietly walk away from any table his name is attached to

KEMAL ÖZGÜR · 1080· 5mo ago · negative0

“securities fraud”Shkreli menjalankan skema yang dijalankan selama lima tahun melibatkan penipuan terhadap investor di dua hedge fund yang ia dirikan: MSMB Capital Management dan MSMB Healthcare

Makimaa · 1211· 5mo ago · negative0

“I don’t trust him.”Martin Shkreli’s role in Web3 feels incredibly polarizing. There’s no denying that he has a very sharp understanding of markets, incentives, and decentralized systems. His ability to break down protocols and identify weaknesses or opportunities is something many people in crypto still pay attention to. At the same time, his reputation continues to follow him everywhere. The Daraprim controversy and his fraud conviction created a level of distrust that many in the space simply cannot ignore. As a result, some see him as a brilliant but controversial strategist, while others view him as a long-term reputational risk for any ecosystem he touches.

Franklinn · 1391· 5mo ago · neutral0

“tidy”I hope my comments are complete, correct, and appropriate, and that they have a good and positive impact, because as far as I know, he is one of the most active personalities and educated users, and I hope he continues in this style and makes his knowledge available.

M A J I D · 1254· 5mo ago0

“Pharma Boy”I first came across Martin during the $MSI token controversy back in 2022. The token eventually ended up in a rug pull, and while there has never been conclusive evidence that he was directly responsible, he was one of the people publicly endorsing the project. He later claimed that his account had been compromised, but by that point many people in the community were no longer willing to accept that explanation. He remains a highly controversial figure. On one hand, he clearly comes across as very intelligent and capable. On the other hand, many critics argue that some of his decisions and actions have raised serious questions about how that intelligence has been used. Because of that, opinions about him tend to be sharply divided within the community.

Psychee.base.eth · 1243· 5mo ago · neutral0

“Smart in finance but Controversial Everywhere Else”Martin Shkreli clearly knows finance and markets well, but his reputation is hard to ignore. The drug price controversy, insider trading case, & time in prison made many people lose trust in him completely. Even his crypto projects often feel driven more by hype than long term value. Personally, I’d stay cautious with anything connected to Martin. He is definitely intelligent, but intelligence without ethics can easily become dangerous for others..

GOJO.base.eth · 1054· 5mo ago · negative0

“I’m really curious what kind of wallet this is. It buys huge percentages in several coins under a $50k market cap, but t”

Sickboyx base.eth · 1077· 5mo ago · neutral0

“not someone i would blindly trust”First look at Martin Shkreli and Godel Terminal I went to check out his profile and the Godel Terminal site because I wanted to see what he is actually building. The product looks more serious than I expected. It seems focused on giving traders and investors a fast financial terminal with market data, charts, filings, news, commands, and global coverage in one place. What I liked is that the site does not feel like a random hype page. It is pretty direct about what the tool does, and the terminal-style approach makes sense for people who follow markets closely. Of course, Martin Shkreli is a name that comes with a lot of history, so I would still keep a critical eye on it. But purely from a product first impression, Godel Terminal looks interesting and worth watching.

alex69 · 1343· 5mo ago · neutral0

“Clearly smart, but exhausting to listen to”Martin Shkreli is knowledgeable when it comes to biotech, markets, and investing, but the constant arrogance and need for attention completely overshadow it. A lot of the time, it feels like he enjoys provoking people more than actually contributing anything meaningful. Even when he makes a good point, the attitude behind it makes him hard to take seriously. He comes off as someone who cares more about being controversial and looking smarter than everyone else than earning genuine respect.

OLE | DEGENKING · 1201· 5mo ago · negative0

“Smart guy, terrible energy”Martin Shkreli is obviously intelligent nobody really denies that. He knows biotech, markets, and internet culture better than most people in the space. But the way he carries himself makes it hard to separate the intelligence from the ego. A lot of his reputation comes from being intentionally provocative, arrogant, and seemingly proud of making people upset. Even when he says something insightful, it’s usually wrapped in sarcasm, drama, or attention-seeking behavior that turns people off immediately. Feels like one of those people who always needs to be the smartest person in the room, even if it means being completely unlikeable.

Sikret · 1226· 5mo ago · negative0

“Great web3 investor”The most hated man in America (2015–2017 era) has re-emerged as a surprisingly active, sharp-witted, and technically engaged founder in fintech/software after serving ~4.5 years in federal prison. Still polarizing, still arrogant, but undeniably intelligent and now focused on building rather than just trolling.

switch · 1060· 5mo ago0

“Martin Shkreli: The Notorious "Pharma Bro" Who Shook Wall Street and the Pharmaceutical Industry”Martin Shkreli is an American investor, entrepreneur, and former hedge fund manager born on March 17, 1983, in Brooklyn, New York, to Albanian and Croatian immigrant parents who worked as janitors. He gained worldwide notoriety as "Pharma Bro" after founding several hedge funds including Elea Capital, MSMB Capital Management, and MSMB Healthcare. He later entered the pharmaceutical industry by founding Retrophin in 2011 and Turing Pharmaceuticals in 2015. In the fields of finance and biotechnology, Shkreli operated as an aggressive trader known for short selling biotech stocks and acquiring pharmaceutical companies to maximize profits. His most famous and highly controversial contribution was dramatically raising the price of Daraprim (pyrimethamine), a critical drug used to treat AIDS and toxoplasmosis patients, from $13.50 to $750 per pill an increase of over 5,500% overnight in September 2015. This move sparked global outrage as a clear example of price gouging, even though it was legally permissible, and successfully highlighted major issues surrounding exorbitant drug prices and regulatory loopholes in the United States pharmaceutical industry.Beyond the drug price controversy, Shkreli also made headlines by purchasing the Wu Tang Clan album Once Upon a Time in Shaolin for $2 million as the world’s only copy. He holds several patents, including ones related to pantothenate derivatives for treating neurological disorders. His career has been marked by serious legal troubles; in 2018, he was sentenced to seven years in prison for securities fraud and running a Ponzi-like scheme involving his hedge funds and Retrophin. He was released early in May 2022 and is now permanently banned from the pharmaceutical industry and from serving as an officer of any public company. After prison, Shkreli shifted his focus to software and fintech as co founder of DL Software and Gödel Systems. He has developed platforms like Druglike for drug discovery and remains active writing newsletters on Substack about technology, AI agents, and startups, while building communities on Discord. Despite his controversial reputation, he continues to be a polarizing figure who sparks important public discussions on business ethics, drug innovation, and market dynamics.

sanzjago · 1234· 5mo ago · neutral0

‹ Back72 of 114 · most upvoted firstMore ›